Cargando…

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study

Although diuretics are often prescribed to control fluid overload, they can change Chronic kidney disease-mineral and bone disorder (CKD-MBD) parameters. Previous studies have shown an association between diuretic prescription and changes in both calciuria and parathormone levels. However, the causa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasco, Raquel F.V., Takayama, Liliam, Pereira, Rosa M.R., Moyses, Rosa M.A., Elias, Rosilene M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811042/ https://www.ncbi.nlm.nih.gov/pubmed/33490315 http://dx.doi.org/10.1016/j.bonr.2021.100746

Ejemplares similares

CKD-MBD diagnosis: biochemical abnormalities
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013)

CKD-MBD after kidney transplantation
por: Wesseling-Perry, Katherine, et al.
Publicado: (2011)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

The Role of Vitamin K in CKD-MBD
por: Fusaro, Maria, et al.
Publicado: (2022)

Self-reported and objective sleep duration in patients with CKD: are they telling the same story?
por: de Carvalho, Kalyanna S. Bezerra, et al.
Publicado: (2022)

Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses
por: White, Julianne M., et al.
Publicado: (2023)

Hydrochlorothiazide does not increase furosemide's effects in end-stage renal disease
por: Huh, Wooseong, et al.
Publicado: (2017)

Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

Clinical significance of parathyroid intervention on CKD-MBD management
por: Ogata, Hiroaki, et al.
Publicado: (2008)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
por: Waziri, Bala, et al.
Publicado: (2019)

Potential Interaction of Green Tea Extract with Hydrochlorothiazide on Diuretic Activity in Rats
por: Chakraborty, Manodeep, et al.
Publicado: (2014)

Captopril Combined with Furosemide or Hydrochlorothiazide Affects Macrophage Functions in Mouse Contact Hypersensitivity Response
por: Bryniarski, Paweł, et al.
Publicado: (2021)

New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
por: Escudero, Victor Joaquin, et al.
Publicado: (2022)

Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis
por: Lee, Tao Han, et al.
Publicado: (2021)

Gaps between Global Guidelines and Local Practices in CKD-MBD
por: Kim, Gheun-Ho
Publicado: (2014)

Which Vitamin D in CKD-MBD? The Time of Burning Questions
por: Galassi, Andrea, et al.
Publicado: (2013)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
por: Na, K. Y., et al.
Publicado: (2001)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020)

Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
por: Wetmore, James B., et al.
Publicado: (2021)

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
por: Vervloet, Marc G
Publicado: (2023)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Association of furosemide or hydrochlorothiazide use with risk of atrial fibrillation post pacemaker implantation among elderly patients
por: Lin, Da-Wei, et al.
Publicado: (2021)

Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus
por: Hall, Michael E, et al.
Publicado: (2014)

Skeletal and cardiovascular consequences of a positive calcium balance during hemodialysis
por: Elias, Rosilene M., et al.
Publicado: (2020)

A retrospective study of 14 dogs with advanced heart failure treated with loop diuretics and hydrochlorothiazide
por: Iwanaga, Koji, et al.
Publicado: (2021)

Magnesium—A More Important Role in CKD–MBD than We Thought
por: Peride, Ileana, et al.
Publicado: (2022)

Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide
por: Flack, J M
Publicado: (2007)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Parathyroid Hormone: A Uremic Toxin
por: Duque, Eduardo J., et al.
Publicado: (2020)

Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure
por: Loughran, Kerry A., et al.
Publicado: (2020)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9snjkud29v5fadkhrcts9q303n